1nessAgency

1nessAgency Insights

Business EN ↓ 264 episodes

Healthcare digital marketing insights narrated by AI. Compliance strategy, patient acquisition, and AI optimization from 1nessAgency.

Be sure to visit the podcast's website and support the creator: www.1nessagency.com

Author

1nessAgency

Category

Business

Podcast website

www.1nessagency.com

Latest episode

Nov 14, 2026

Where to listen?

Podcasts in the app Replaio Radio Coming soon

Podcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts

Get it on Google Play Install for free Android 10M+ downloads · 4.7+ rating iOS soon

Episodes

Rialtic Bets on AI to Fix Broken Healthcare Payment System Through Exponential Merger 01.06.2026

The merger of Rialtic, an Atlanta-based cloud platform for payment accuracy founded in 2020, and Exponential AI, whose real-time decision intelligence platform Enso is already deployed across leading U.S. health plans and systems, creates one of the most comprehensive claim-lifecycle technology suit

Overdose Hospitalizes Woman as Telehealth Firms Exploit Gaps in Drug Oversight 01.06.2026

A compliance consultant from Tennessee followed her telehealth provider's dosing instructions precisely. Within 24 hours, she was hospitalized with a GLP-1 overdose, the prescribed dose was nearly nine times what patients typically receive for their first injection. The January 2026 incident highli

Salesforce Buys Contentful to Close the AI Gap Healthcare Marketing Ignores 01.06.2026

Salesforce signed a definitive agreement on June 1, 2026 to acquire Contentful, the composable content platform, in a move that exposes the infrastructure gap separating static healthcare marketing from AI-driven personalization . The transaction, expected to close in Salesforce's third quarter of f

Rialtic Bets on AI to Fix Broken Healthcare Payment System Through Exponential Merger 01.06.2026

The merger of Rialtic, an Atlanta-based cloud platform for payment accuracy founded in 2020, and Exponential AI, whose real-time decision intelligence platform Enso is already deployed across leading U.S. health plans and systems, creates one of the most comprehensive claim-lifecycle technology suit

Overdose Hospitalizes Woman as Telehealth Firms Exploit Gaps in Drug Oversight 01.06.2026

A compliance consultant from Tennessee followed her telehealth provider's dosing instructions precisely. Within 24 hours, she was hospitalized with a GLP-1 overdose — the prescribed dose was nearly nine times what patients typically receive for their first injection. The January 2026 incident highli

Teladoc Health Partners With Walmart on $89 Virtual Visits as AI Adoption Reshapes Healthcare's Front Door 31.05.2026

Medical practices are moving faster than health systems on AI adoption, and the gap is widening. Approximately 12.5% of medical practices have deployed AI receptionists as of May 2026, with adoption concentrated among practices with 4 to 10 providers, according to The Algorithm's latest research . S

Teladoc Health Partners With Walmart on $89 Virtual Visits as AI Adoption Reshapes Healthcare's Front Door 31.05.2026

Medical practices are moving faster than health systems on AI adoption, and the gap is widening. Approximately 12.5% of medical practices have deployed AI receptionists as of May 2026, with adoption concentrated among practices with 4 to 10 providers, according to The Algorithm's latest research . S

Advocate Health Deploys AI to Capture Cancer Patients Before They Leave For Research Centers 28.05.2026

Advocate Health has launched an artificial intelligence partnership focused on clinical trial matching in 2026, marking a strategic shift in how large health systems position themselves in the competitive landscape of specialty care and patient retention. For healthcare marketers, this development r

Advocate Health Deploys AI to Capture Cancer Patients Before They Leave For Research Centers 28.05.2026

Advocate Health has launched an artificial intelligence partnership focused on clinical trial matching in 2026, marking a strategic shift in how large health systems position themselves in the competitive landscape of specialty care and patient retention. For healthcare marketers, this development r

Roche Bets Billions on PathAI to Leapfrog Rivals in the Race For AI-Powered Pathology 27.05.2026

Roche's May 2026 definitive merger agreement to acquire PathAI marks the largest consolidation of AI-driven diagnostic capabilities inside a single global diagnostics portfolio in recent memory , and it reshapes the competitive terrain for every health system, oncology practice, and diagnostic lab t

Knit Health's Behavioral AI Learns How Doctors Actually Think, Reshaping Patient Routes 27.05.2026

A UC Berkeley spin-out just secured $11.6 million in seed funding to build something healthcare has never seen: an AI model that learns not from medical textbooks, but from how clinicians actually make decisions . Knit Health emerged from stealth in May 2026 with a Large Clinical Behavior Model (LCB

Penn Medicine's AI Agents Upend Traditional Doctor-Patient Workflows 27.05.2026

Penn Medicine, one of the country's most recognized academic health systems, is moving forward with the deployment of AI-powered clinical agents , autonomous or semi-autonomous software systems capable of performing clinical reasoning tasks, triaging patient needs, drafting care summaries, and coord

Roche Bets Billions on PathAI to Leapfrog Rivals in the Race For AI-Powered Pathology 27.05.2026

Roche's May 2026 definitive merger agreement to acquire PathAI marks the largest consolidation of AI-driven diagnostic capabilities inside a single global diagnostics portfolio in recent memory , and it reshapes the competitive terrain for every health system, oncology practice, and diagnostic lab t

Knit Health's Behavioral AI Learns How Doctors Actually Think, Reshaping Patient Routes 27.05.2026

A UC Berkeley spin-out just secured $11.6 million in seed funding to build something healthcare has never seen: an AI model that learns not from medical textbooks, but from how clinicians actually make decisions . Knit Health emerged from stealth in May 2026 with a Large Clinical Behavior Model (LCB

Penn Medicine's AI Agents Upend Traditional Doctor-Patient Workflows 27.05.2026

Penn Medicine, one of the country's most recognized academic health systems, is moving forward with the deployment of AI-powered clinical agents , autonomous or semi-autonomous software systems capable of performing clinical reasoning tasks, triaging patient needs, drafting care summaries, and coord

Reddit's Patient Data Becomes Battleground as AI Models Fight For Healthcare Conversations 26.05.2026

Reddit CEO Steve Huffman declared in May 2026 that large language models "would not exist as we know them" without Reddit's user-generated content, calling the platform's data "modern oil" for artificial intelligence . Healthcare marketers should pay attention: The battle over conversational data ha

One-and-Done Gene Therapy Upends Decades of Cardiovascular Marketing Playbooks 26.05.2026

A potential gene therapy for lifelong cholesterol management just moved from theoretical to probable, and the implications reach far beyond cardiology wards. Healthcare marketers face a category disruption that will reshape patient acquisition funnels, lifetime value calculations, and the entire pre

FDA Blocks Weight-Loss Drugs From Compounding Pharmacies as Supply Concerns Mount 26.05.2026

The FDA's April 30, 2026 proposal to remove semaglutide, tirzepatide, and liraglutide from the 503B outsourcing facility bulks list marks the most consequential regulatory shift in weight management marketing since these drugs entered the mainstream. For the clinics, telehealth platforms, and med sp

Oura Races Into Public Markets as Wearable Health Trackers Gain Wall Street Appeal 26.05.2026

Oura's move toward the public markets arrives as the wearable health device sector accelerates its pivot from lifestyle accessory to clinical tool. The company has pursued partnerships with health systems and researchers to validate its biometric data , heart rate variability, body temperature, resp

Reddit's Patient Data Becomes Battleground as AI Models Fight For Healthcare Conversations 26.05.2026

Reddit CEO Steve Huffman declared in May 2026 that large language models "would not exist as we know them" without Reddit's user-generated content, calling the platform's data "modern oil" for artificial intelligence . Healthcare marketers should pay attention: The battle over conversational data ha

One-and-Done Gene Therapy Upends Decades of Cardiovascular Marketing Playbooks 26.05.2026

A potential gene therapy for lifelong cholesterol management just moved from theoretical to probable, and the implications reach far beyond cardiology wards. Healthcare marketers face a category disruption that will reshape patient acquisition funnels, lifetime value calculations, and the entire pre

FDA Blocks Weight-Loss Drugs From Compounding Pharmacies as Supply Concerns Mount 26.05.2026

The FDA's April 30, 2026 proposal to remove semaglutide, tirzepatide, and liraglutide from the 503B outsourcing facility bulks list marks the most consequential regulatory shift in weight management marketing since these drugs entered the mainstream. For the clinics, telehealth platforms, and med sp

Oura Races Into Public Markets as Wearable Health Trackers Gain Wall Street Appeal 26.05.2026

Oura's move toward the public markets arrives as the wearable health device sector accelerates its pivot from lifestyle accessory to clinical tool. The company has pursued partnerships with health systems and researchers to validate its biometric data , heart rate variability, body temperature, resp

FDA Approves First Non-Antipsychotic Drug For Dementia Agitation, Reshaping Treatment Options 25.05.2026

On April 30, 2026, the FDA approved Auvelity (dextromethorphan hydrobromide and bupropion hydrochloride) for a new indication: treating agitation associated with Alzheimer's disease dementia in adults [1]. The approval is a first of its kind , no non-antipsychotic drug has ever carried this indicati

FDA Approves First Non-Antipsychotic Drug For Dementia Agitation, Reshaping Treatment Options 25.05.2026

On April 30, 2026, the FDA approved Auvelity (dextromethorphan hydrobromide and bupropion hydrochloride) for a new indication: treating agitation associated with Alzheimer's disease dementia in adults [1]. The approval is a first of its kind , no non-antipsychotic drug has ever carried this indicati

Listen to the 1nessAgency Insights podcast in Replaio

Radio and podcasts in one app - free, with no sign-up. Install today and do not miss the launch

Get it on Google Play

Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.